Children with mild asthma achieve peak inspiratory flow rates that allow adequate delivery of mometasone furoate from the Twisthaler® dry powder inhaler.

被引：0

|

作者：

Skoner, D.

Gentile, D.

机构：

来源：

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2008年 / 100卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：A28 / A29

页数：2

相关论文

共 30 条

[21] COPD PATIENTS WITH VARYING SEVERITY OF AIRFLOW LIMITATION ACHIEVE HIGHEST PEAK INSPIRATORY FLOW RATE VIA THE BREEZHALER® INHALER COMPARED TO THE ELLIPTA® OR THE HANDIHALER® DRY POWDER INHALERS
Goyal, P.
Wehbe, L.
Dederichs, J.
Guerin, T.
Moronta, M. C.
Pino, A. V.
Kostikas, K.
Altman, P.
THORAX, 2016, 71 : A246 - A247
[22] CONSISTENCY OF DOSE DELIVERY OF FLUTICASONE FUROATE (FF)/UMECLIDINIUM (UMEC)/VILANTEROL (VI) ACROSS PATIENT RELEVANT INHALATION FLOW RATES FROM A DRY-POWDER INHALER (DPI)
Prime, David
Hamilton, Melanie
Patmore, Oonagh
CHEST, 2019, 156 (04) : 1786A - 1786A
[23] SUBOPTIMAL PEAK INSPIRATORY FLOW (PIF) IN PATIENTS WITH SEVERE COPD DOES NOT IMPACT EFFECTIVE DRUG DELIVERY OF AN INHALED TRIPLE THERAPY DRY POWDER INHALER (DPI)
Ferguson, Gary T.
CHEST, 2022, 162 (04) : 1881A - 1883A
[24] Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials
Annette Kainu
Ville A. Vartiainen
Witold Mazur
Hanna Hisinger-Mölkänen
Federico Lavorini
Christer Janson
Martin Andersson
Pulmonary Therapy, 2024, 10 : 133 - 142
[25] Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials
Kainu, Annette
Vartiainen, Ville A.
Mazur, Witold
Hisinger-Molkanen, Hanna
Lavorini, Federico
Janson, Christer
Andersson, Martin
PULMONARY THERAPY, 2024, 10 (01) : 133 - 142
[26] Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler
Chavan, V
Dalby, R
AAPS PHARMSCI, 2002, 4 (02):
[27] Novel system to investigate the effects of inhaled volume and rates of rise in simulated inspiratory air flow on fine particle output from a dry powder inhaler
Chavan V.
Dalby R.
AAPS PharmSci, 4 (2):
[28] Assessment of in vitro delivered dose of formoterol via a new multi-dose dry powder inhaler: Reliable delivery over a range of clinically relevant inspiratory flow rates
Singh, D
Gilchrist, P
Niederlander, C
Haeberlin, B
Yegen, U
Gebe, G
CHEST, 2004, 126 (04) : 808S - 808S
[29] Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma
Amirav, I
Newhouse, MT
Mansour, Y
PEDIATRIC PULMONOLOGY, 2005, 39 (05) : 447 - 451
[30] Twice-daily treatment with mometasone furoate dry-powder inhaler 100 micrograms did not exert a systemic effect as measured by plasma cortisol levels: Findings from a pediatric asthma placebo-controlled clinical trial
Skoner, David P.
Gentile, Deborah A.
Angelini, Betty
CHEST, 2007, 132 (04) : 602S - 602S